MD Anderson personalized my prostate cancer treatment
After reviewing all of his prostate cancer treatment options, Mike Zenner chose proton therapy for the minimal long-term side effects.
Related Articles
Richter transformation: What chronic lymphocytic leukemia (CLL) patients should know
Patients who have undergone treatment for chronic lymphocytic leukemia (CLL) may experience Richter transformation, a rare syndrome in which CLL turns into a more aggressive…
Study opens new avenue for immunotherapy drug development
In a new study published today in Nature Biomedical Engineering, researchers at The University of Texas MD Anderson Cancer Center have designed a new method…
Sponsored: MD Anderson Cancer Center’s ‘Sprint For Life’ 5K Race/Walk
Sprint For Life raises awareness of ovarian cancer in the community and raises important research funds.
How long does it take chemotherapy to shrink tumors?
How long does it take for chemotherapy to start shrinking a tumor? Head and neck specialist and thoracic medical oncologist Janet Tu, M.D., weighs in.
Colorectal cancer survivor and employee: I now understand what makes MD Anderson No. 1
As a 12-year employee of MD Anderson, Erica Pettye never expected to face cancer herself. But the care she received here showed her why MD…
Four MD Anderson researchers elected AAAS Fellows
HOUSTON ― Recognizing their significant impacts in the realm of cancer care and research, four researchers at The University of Texas MD Anderson Cancer Center…
Need CAR T cell therapy? Here’s what to expect
How long does it take to get CAR T cell therapy? What eligibility requirements must be met to receive it? We checked in with lymphoma…
Inflammatory breast cancer: 14 things to know
Inflammatory breast cancer is a rare, aggressive form of the disease that’s frequently misdiagnosed. Wendy Woodward, M.D., Ph.D., explains why speed and an accurate diagnosis…
Masarova on the Latest Updates Across Myeloproliferative Neoplasms
Lucia Masarova, MD, PhD, discusses some of the latest updates across myeloproliferative neoplasms.
Basic Focus-Assessed Transthoracic Echocardiography (FATE) Workshop – MDA – Continuing Education (CE)
MDA, Basic Focus-Assessed Transthoracic Echocardiography (FATE) Workshop, 5/11/2024 7:30:00 AM – 5/11/2024 2:30:00 PM, The FATE protocol is one of several focused cardiac ultrasound (FOCUS)…